拓邦股份(002139.SZ):在人形機器人領域已接到部分客户的小批量訂單
格隆匯3月12日丨拓邦股份(002139.SZ)於近期投資者關係活動表示,公司自2008年推出空心杯電機產品後,2010年率先用於醫療領域,2014年成為多個國家的空心杯市場的卓越供應商。截至目前已實現工業機器人、電動工具、醫療器械、智能家居等多領域的成熟應用,在人形機器人領域已接到部分客户的小批量訂單,並拓展了新能源汽車車內娛樂和智能化的應用,預計今後將實現該場景的批量應用。在工業機器人領域,公司除空心杯電機外,還為行業客户提供伺服驅動及伺服電機等產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.